Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 1
2017 2
2018 3
2019 3
2020 2
2021 8
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Crossed Cerebellar Diaschisis in Alzheimer's Disease.
Reesink FE, García DV, Sánchez-Catasús CA, Peretti DE, Willemsen AT, Boellaard R, Meles SK, Huitema RB, de Jong BM, Dierckx RA, De Deyn PP. Reesink FE, et al. Curr Alzheimer Res. 2018;15(13):1267-1275. doi: 10.2174/1567205015666180913102615. Curr Alzheimer Res. 2018. PMID: 30210001
Amyloid burden quantification depends on PET and MR image processing methodology.
Kolinger GD, Vállez García D, Willemsen ATM, Reesink FE, de Jong BM, Dierckx RAJO, De Deyn PP, Boellaard R. Kolinger GD, et al. Among authors: reesink fe. PLoS One. 2021 Mar 5;16(3):e0248122. doi: 10.1371/journal.pone.0248122. eCollection 2021. PLoS One. 2021. PMID: 33667281 Free PMC article. Clinical Trial.
Planning in amnestic mild cognitive impairment: an fMRI study.
Lejko N, Tumati S, Opmeer EM, Marsman JC, Reesink FE, De Deyn PP, Aleman A, Ćurčić-Blake B. Lejko N, et al. Among authors: reesink fe. Exp Gerontol. 2022 Mar;159:111673. doi: 10.1016/j.exger.2021.111673. Epub 2021 Dec 24. Exp Gerontol. 2022. PMID: 34958871 Free article.
Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia.
Naudé PJW, Ramakers IHGB, van der Flier WM, Jiskoot LC, Reesink FE, Claassen JAHR, Koek HL, Eisel ULM, De Deyn PP. Naudé PJW, et al. Among authors: reesink fe. Neurobiol Aging. 2021 Nov;107:1-10. doi: 10.1016/j.neurobiolaging.2021.07.001. Epub 2021 Jul 10. Neurobiol Aging. 2021. PMID: 34365256 Free article.
Knowledge, health beliefs and attitudes towards dementia and dementia risk reduction among descendants of people with dementia: a qualitative study using focus group discussions.
Vrijsen J, Maeckelberghe ELM, Broekstra R, de Vries JJ, Abu-Hanna A, De Deyn PP, Voshaar RCO, Reesink FE, Buskens E, de Rooij SE, Smidt N. Vrijsen J, et al. Among authors: reesink fe. BMC Public Health. 2021 Jul 7;21(1):1344. doi: 10.1186/s12889-021-11415-2. BMC Public Health. 2021. PMID: 34233658 Free PMC article.
Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report.
Kalteren WS, Schreurs MWJ, Jorritsma-Smit A, Touw DJ, de Jong JW, Zweers PGMA, Reesink FE. Kalteren WS, et al. Among authors: reesink fe. Br J Clin Pharmacol. 2017 Oct;83(10):2330-2332. doi: 10.1111/bcp.13338. Epub 2017 Jun 19. Br J Clin Pharmacol. 2017. PMID: 28631271 Free PMC article. No abstract available.
22 results